| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC | Chief Executive Officer, Director | Common Stock | 176K | $12.2M | $69.44 | Mar 17, 2025 | Direct |
| BIOMARIN PHARMACEUTICAL INC | Chief Executive Officer, Director | Stock Option (Right to Buy Common Stock) | 61.8K | Mar 17, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BMRN | BIOMARIN PHARMACEUTICAL INC | Mar 14, 2025 | 3 | -$204K | 4 | Mar 18, 2025 | Chief Executive Officer, Director |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Nov 29, 2024 | 2 | -$927K | 4 | Dec 3, 2024 | Chief Executive Officer, Director |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Mar 15, 2024 | 2 | $0 | 4 | Mar 19, 2024 | Chief Executive Officer, Director |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Dec 1, 2023 | 3 | $0 | 4 | Dec 5, 2023 | Chief Executive Officer, Director |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Dec 1, 2023 | 0 | $0 | 3 | Dec 5, 2023 | Chief Executive Officer, Director |